Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type

SIMPLE SUMMARY: The progress of next-generation sequencing technologies has raised huge expectations for precision-medicine therapy approaches in breast cancer and triple-negative breast cancer. Targeted therapy strategies such as ICIs, EGFRi, PARPi, ADCs, CD44i, OVs, and GLUT1i are innovative thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Subhan, Md Abdus, Parveen, Farzana, Shah, Hassan, Yalamarty, Satya Siva Kishan, Ataide, Janaína Artem, Torchilin, Valdimir P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137302/
https://www.ncbi.nlm.nih.gov/pubmed/37190133
http://dx.doi.org/10.3390/cancers15082204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137302/
https://www.ncbi.nlm.nih.gov/pubmed/37190133
http://dx.doi.org/10.3390/cancers15082204

Ejemplares similares